Market Overview

UPDATE: Goldman Sachs Upgrades Vitamin Shoppe to Buy on Valuation, Secular Growth Outlook

Share:
Related VSI
Wall Street's M&A Chatter From February 23
GNC's CEO And Chairman Both Just Bought A Bunch Of Stock
Mad Money's Jim Cramer Unequivocally States GNC Is A Sell At $8.63 (Seeking Alpha)

Goldman Sachs upgraded Vitamin Shoppe (NYSE: VSI) from Neutral to Buy and raised the price target to $65.00.

Goldman Sachs noted, "Like many growth names in our coverage, VSI has experienced multiple compression of late. We still like the supplement sector's secular growth. Moreover, we like VSI's incremental pursuit of own-brand product and international expansion, which we think brings it marginally closer to GNC's more lucrative operating model. VSI now trades near longrun relative P/E troughs, presenting us with an opportunity to buy into growth at a relative discount."

Vitamin Shoppe closed at $50.62 on Monday.

Latest Ratings for VSI

DateFirmActionFromTo
Jan 2017Goldman SachsDowngradesNeutralSell
Jan 2017Morgan StanleyDowngradesEqual-WeightUnderweight
Nov 2016Morgan StanleyDowngradesOverweightEqual-Weight

View More Analyst Ratings for VSI
View the Latest Analyst Ratings

Posted-In: Goldman SachsAnalyst Color Upgrades Analyst Ratings

 

Related Articles (VSI)

View Comments and Join the Discussion!